A detailed history of Pictet Asset Management Sa transactions in Neogenomics Inc stock. As of the latest transaction made, Pictet Asset Management Sa holds 13,166 shares of NEO stock, worth $198,016. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,166
Previous 13,166 -0.0%
Holding current value
$198,016
Previous $229,000 7.86%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$6.45 - $12.07 $84,920 - $158,913
13,166 New
13,166 $122,000
Q1 2022

May 13, 2022

SELL
$12.15 - $35.28 $92,522 - $268,657
-7,615 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$41.66 - $52.52 $317,240 - $399,939
7,615 New
7,615 $367,000

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.89B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Pictet Asset Management Sa Portfolio

Follow Pictet Asset Management Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet Asset Management Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet Asset Management Sa with notifications on news.